United Therapeutics Investment Purchases increased by 34.9% to $701.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.4%, from $692.30M to $701.70M. Over 4 years (FY 2021 to FY 2025), Investment Purchases shows an upward trend with a 15.8% CAGR.
An increase may indicate a strategy to earn interest on excess cash, while a decrease may suggest a need for cash for operations or debt repayment.
This metric captures the cash outflow for the purchase of marketable securities, such as stocks, bonds, or other financi...
Standard for large-cap companies with significant cash reserves; peers manage these portfolios to balance liquidity needs with yield generation.
purchases_of_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $310.40M | $529.00M | $496.90M | $477.60M | $530.50M | $270.00M | $430.50M | $889.50M | $672.00M | $644.80M | $308.00M | $529.30M | $230.50M | $407.80M | $478.50M | $692.30M | $1.81B | $385.90M | $520.30M | $701.70M |
| QoQ Change | — | +70.4% | -6.1% | -3.9% | +11.1% | -49.1% | +59.4% | +106.6% | -24.5% | -4.0% | -52.2% | +71.9% | -56.5% | +76.9% | +17.3% | +44.7% | +161.0% | -78.6% | +34.8% | +34.9% |
| YoY Change | — | — | — | — | +70.9% | -49.0% | -13.4% | +86.2% | +26.7% | +138.8% | -28.5% | -40.5% | -65.7% | -36.8% | +55.4% | +30.8% | +683.9% | -5.4% | +8.7% | +1.4% |